ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Cell Cycle >PLK inhibitors >NMS-P937 (NMS1286937)
NMS-P937 (NMS1286937)

- CAS No.
- 1034616-18-6
- Chemical Name:
- NMS-P937 (NMS1286937)
- Synonyms
- PCM075;CS-1243;PCM 075;PCM-075;NMS-P937;NMS-1286937;NMS-1286937,NMS-P937;NMS-P937 (NMS1286937);Onvansertib (NMS-P937);Onvansertib(NMS-1286937
- CBNumber:
- CB12715659
- Molecular Formula:
- C24H27F3N8O3
- Molecular Weight:
- 532.52
- MOL File:
- 1034616-18-6.mol
- Modify Date:
- 2025/4/28 21:36:36
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H315-H319 | |||||||||
Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 | |||||||||
NFPA 704 |
|
NMS-P937 (NMS1286937) Preparation Products And Raw materials
Raw materials
Preparation Products
NMS-P937 (NMS1286937) Suppliers
Global( 119)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6739 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6754 | 58 | Inquiry |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 33024 | 60 | Inquiry |
BOC Sciences | +1-631-485-4226 | United States | 19552 | 58 | Inquiry |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 32222 | 58 | Inquiry |
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | China | 22855 | 58 | Inquiry |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | China | 10473 | 58 | Inquiry |
InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6391 | 58 | Inquiry |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | China | 49734 | 58 | Inquiry |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | China | 3135 | 58 | Inquiry |
1034616-18-6(NMS-P937 (NMS1286937))Related Search:
chevron_left
1of2
chevron_right
NMS-1286937
4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
NMS-P937 (NMS1286937)
NMS-P937
NMS-1286937,NMS-P937
1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
CS-1243
1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-
NMS-P937 (NMS1286937) USP/EP/BP
Onvansertib(NMS-1286937
1-(2-Hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
Onvansertib (NMS-P937)
PCM 075
PCM075
PCM-075
Onvansertib, 10 mM in DMSO
1034616-18-6
C24H27F3N8O3
Inhibitors